pH/Redox/Lysozyme-Sensitive Hybrid Nanocarriers With Transformable Size for Multistage Drug Delivery
The majority of current nanocarriers in cancer treatment fail to deliver encapsulated cargos to their final targets at therapeutic levels, which decreases the ultimate efficacy. In this work, a novel core–shell nanocarrier with a biodegradable property was synthesized for efficient drug release and...
Main Authors: | Zhe Liu, Dong Zhou, Lan Liao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-04-01
|
Series: | Frontiers in Bioengineering and Biotechnology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fbioe.2022.882308/full |
Similar Items
-
Overcoming the Tumor Collagen Barriers: A Multistage Drug Delivery Strategy for DDR1‐Mediated Resistant Colorectal Cancer Therapy
by: Guangman Cui, et al.
Published: (2024-09-01) -
pH and Redox Dual-Sensitive Covalent Organic Framework Nanocarriers to Resolve the Dilemma Between Extracellular Drug Loading and Intracellular Drug Release
by: Chaoyu Wang, et al.
Published: (2020-06-01) -
K. Zheng et al. Gold-nanoparticle-based multistage drug delivery system for antitumor therapy
by: Kaikai Zheng, et al.
Published: (2022-12-01) -
Polypeptides-Based Nanocarriers in Tumor Therapy
by: Juhua You, et al.
Published: (2024-09-01) -
Advancements in Stimulus-Responsive Co-Delivery Nanocarriers for Enhanced Cancer Immunotherapy
by: Zhang MR, et al.
Published: (2024-04-01)